Dapsone
( DrugBank: Dapsone / KEGG DRUG: Dapsone )
5 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
35 | Pemphigus | 1 |
42 | Polyarteritis nodosa | 1 |
60 | Aplastic anemia | 2 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
84 | Sarcoidosis | 1 |
162 | Pemphigoid | 2 |
35. Pemphigus
Clinical trials : 120 / Drugs : 109 - (DrugBank : 40) / Drug target genes : 28 - Drug target pathways : 167
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
42. Polyarteritis nodosa
Clinical trials : 15 / Drugs : 22 - (DrugBank : 16) / Drug target genes : 26 - Drug target pathways : 104
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
60. Aplastic anemia
Clinical trials : 305 / Drugs : 328 - (DrugBank : 91) / Drug target genes : 60 - Drug target pathways : 183
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
84. Sarcoidosis
Clinical trials : 175 / Drugs : 189 - (DrugBank : 80) / Drug target genes : 74 - Drug target pathways : 177
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
162. Pemphigoid
Clinical trials : 128 / Drugs : 108 - (DrugBank : 49) / Drug target genes : 35 - Drug target pathways : 143
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|